Russian doll drug delivery technology is also effective against Staphylococcus aureus infections
Researchers from the Innovation in Respiratory Infections and Tuberculosis Diagnosis Group at the IGTP have successfully used their Russian doll nanoparticle technology for antibiotic delivery against a second micro-organism. This study demonstrates that the use of nanoparticles is a potentially powerful weapon against a variety of diseases caused by infectious bacteria.
More efficient, reliable methods for Hepatitis C testing in vulnerable groups
In the latest installment of their work to reduce hepatitis C virus in Catalonia, and as part of the worldwide campaign, Members of the Clinical Virology and New Diagnostic Tools Group at the IGTP, led by Elisa Martró have found that two diagnostic tests that can be carried out at the point of care are simple and effective methods for testing people who inject drugs (PWID), a population particlarly vulnerable to hepatitis C. The paper is publishedin the International Journal of Drug Policy.
Spain currently has 124,300 active cases of COVID-19 according to the mathmatical model developed by the UPC and IGTP
Madrid, Catalonia, Castile and León and Castile la Mancha are the autonomous regions with the highest accumulated numbers of active cases, in contrast, the Canary Islands, Cantabria, La Rioja, Murcia and Asturias have the lowest numbers of active cases. The data forms part of the study of the evolution of the pandemic based on mathematical models being carried out by the multi-disciplinary team of researchers of the UPC and IGTP.
The malaria parasite ‘P. vivax’ can remain in the spleen upon expression of certain proteins
The malaria parasite Plasmodium vivax can adhere to human spleen cells through the expression of so-called variant proteins. These are the conclusions of a study led by the Barcelona Institute for Global health (ISGlobal), an institution supported by "la Caixa" and the Germans Trias i Pujol Research Institute (IGTP). The results, published in PNAS, suggest that this could represent an additional challenge to eliminating the disease.
The IGTP participates in an international project to validate serological tests for COVID-19
The malaria parasite Plasmodium vivax can adhere to human spleen cells through the expression of so-called variant proteins. These are the conclusions of a study led by the Barcelona Institute for Global health (ISGlobal), an institution supported by "la Caixa" and the Germans Trias i Pujol Research Institute (IGTP). The results, published in PNAS, suggest that this could represent an additional challenge to eliminating the disease.
Our seminar activities are now online The links to join sessions will be on our events pages on the web
Coffee Talks- 9.30-10.00 every Wednesday see the June talks here IGTP COVID-19 ONLINE SeminarsMonday 9.00 every 15 days See the next seminar here IRISCAT COVID-19 Seminars - Wednesday 16.00 every 15 days (more information soon)
(These last two will be on alternate weeks)
Wednesday 3 June 09.30 IGTP COFFEE TALKS ONLINE
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Sergio Montaner, Plasmodium vivax and exosomes research group (PvREX) Group
Available on Teams - more info on the website
Wednesday 3 June 13:00-14:00 CET
How to Commercialize your Biomarker Discovery,
The webinar is organized by the BIC consortium, who aim to create tools for supporting and overcoming the challenges of biomarker commercialization. This project is co-financed by the European Regional Development Fund through the Interreg Baltic Sea Region Programme. For more information you can consult the webpage of the consortium: https://biomarker.nu/home/
Wednesday 3 June 16.00 B·ARGO TRANSLATIONAL SESSIONS
Microambient tumoral en el pronòstic del càncer de pàncrees. Estudi de la secreció de citoquines com a biomarcadors en tumors digestius Laura Layos, ICO-B∙ARGO/SOM Eva Martinez Balibrea, ICO-ProCure/PMPPC-IGTP For information on how to join please see the website
Wednesday 10 June 09.30-10.00 IGTP COFFEE TALKS ON-LINE
Prenatal betamethasone treatment in the development of type 1 diabetes mellitus David Perna, Immunology of Diabetes Group For information on how to connect please see the website
SAVE THE DATE
Wednesday 10 June 16.00 IRISCAT COVID-19 SEMINARS
Julià Blanco, IrsiCaixa, IGTP
More information on our website soon
Monday 15 June 09.00 IGTP COVID-19 SEMINARS
Assessing the psycho-social impact of the COVID-19 epidemic COM-COVID Cristina Vilaplana, PI in the Experimental Tuberculosis Unit and Coordinator of the SMA-TB Project More information
FUNDRAISNG
Two new solidarity initiatives give a percentage of sales to biomedical research on COVID-19 at the IGTP
The IGTP is receiving support from several initiatives to raise money for research into COVID-19. One of the most recent actions has been a proposal from the entrepreneur Berta López, who will donate 5% of the sales from the page heroesincapashop.com to biomedical research into coronavirus at the IGTP.
This Newsletter is for information only Please check all information on the corresponding sites
The IGTP is not responsible for the content of webpages that the user can access through links in this newsletter. The IGTP cannot examine or control the content of other sites on the web, nor can it guarantee the availability, truth, accuracy, validity or legality of sites that are not its property, but that can be accessed via links.